Clinical Trial: The Impact of Neut During KCL Replacement on Pain and Incidence of Phlebitis

Study Status: Enrolling by invitation
Recruit Status: Enrolling by invitation
Study Type: Interventional

Official Title: The Impact of 4% Sodium Bicarbonate Additive During Potassium Chloride Replacement on Pain and Incidence of Phlebitis for Adult Patients in a Medical Surgical Unit: A Randomized Double Blinded Control

Brief Summary: The purpose of this study is to examine the impact of 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy for adult patients in a Medical/Surgical unit. Using a randomized controlled double blinded experimental study design, patients who are 21 years or older are alert, awake, and oriented at the time of enrollment and have been ordered peripheral intravenous potassium chloride replacement will be recruited from one Medical/Surgical during the first 24-48 hours of their admission.

Detailed Summary:

The specific aim of the study is:

Aim 1: To compare patient outcomes (phlebitis, pain at peripheral IV insertion site, frequency of changing IV access, and time for administration) between the experimental (4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy) and control (standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy) groups.

Aim 2: To compare number and type of nursing interventions done during peripheral intravenous potassium chloride replacement therapy between the experimental (4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy) and control (standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy) groups.

Aim 3: To compare attrition rates and reasons between the experimental (4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy) and control (standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy) groups.

Sponsor: Baptist Health South Florida

Current Primary Outcome: Patient outcomes between the experimental and control groups. [ Time Frame: 1 year ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

• Number and type of nursing interventions done during peripheral intravenous potassium chloride replacement therapy between experimental and control groups [ Time Frame: 1 year ]

  experimental - 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy

  control - standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy

• Attrition rates and reasons between the experimental and control groups [ Time Frame: 1 year ]

  experimental - 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy.

  control - standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy

Original Secondary Outcome: Same as current

Information By: Baptist Health South Florida

Dates:
Date Received: February 24, 2014
Date Started: February 2014
Date Completion: February 2018
Last Updated: January 30, 2017
Last Verified: January 2017